EI
CHTP

EAM Investors’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

EAM Investors’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-311,422
Closed -$1.72M – 428
2014
Q1 		$1.72M Sell
311,422
-138,988
-31% -$698K 0.31% 119
2013
Q4 		$2M Sell
450,410
-2,892
-0.6% -$9.77K 0.36% 87
2013
Q3 		$1.36M Buy
+453,302
New +$1.3M 0.27% 140

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

EAM Investors's CHTP Position: Q2 2014 in Review

EAM Investors sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 311,422 shares — an estimated $1.72M sold.

EAM Investors first reported a position in CHTP in Q3 2013 and held it in 3 quarters. The position peaked at $2M in Q4 2013. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • EAM Investors reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • EAM Investors sold 311,422 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $1.72M.
  • EAM Investors first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q3 2013 and held it in 3 quarters.
  • EAM Investors's CHELSEA THERAPEUTICS INT'L LTD position peaked at $2M in Q4 2013.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on EAM Investors's 13F filing for Q2 2014, filed 11 Aug 2014.